Chief Science Officer Robert Hofmeister sold $382K of Tcr2 Therapeutics Inc.

Sold$382,000

$19.10Price

20,000Shares

−34%Stake

What TCRR did after the filing

Prices for TCRR after this filing aren't in yet.

Traded Thu, Oct 29. Filed Mon, Nov 2, 9:00 AM ET, before the open. Not investment advice.